CYH Community Health Systems Inc.

Community Health Systems Announces That Rachel A. Seifert, Executive Vice President, Secretary and General Counsel, Will Retire at the End of the First Quarter

Community Health Systems, Inc. (NYSE: CYH) announced today that Rachel A. Seifert, Executive Vice President, Secretary and General Counsel, will retire at the end of March 2017. Seifert has served as the Company’s General Counsel since joining the organization in 1998. Seifert oversees the Company’s legal department and serves as Secretary to the Company’s Board of Directors.

Ben Fordham, who currently serves as Senior Vice President and Chief Litigation Counsel at Community Health Systems, will be appointed Interim General Counsel upon Seifert’s retirement.

Commenting on the announcement, Wayne T. Smith, chairman and chief executive officer of Community Health Systems, Inc., said, “Through nearly two decades of leadership, Rachel Seifert’s range of responsibility has been broad and dynamic. She has provided sharp counsel and management for all of the Company’s legal matters, legal direction in support of all of our major transactions and corporate financing, oversight for SEC compliance, expertise on regulatory matters, and corporate governance support for our Board of Directors. I am deeply grateful to Rachel for her many contributions to our success.”

Seifert is a 19-year veteran of Community Health Systems and has more than 35 years of legal experience. She joined Community Health Systems as the first and only member of the Legal Department and steadily assembled a strong team of attorneys. Prior to joining Community Health Systems, Seifert worked for Columbia/HCA where she served as Vice President and Associate General Counsel after spending seven years in private law practice. She received her law degree and bachelor’s degree from the University of Maryland.

Fordham joined Community Health Systems in 2007 with 29-years of private practice experience in litigation, mergers and acquisitions, general business and health law. Fordham received his undergraduate degree, magna cum laude, from Duke University and his law degree from Vanderbilt University.

About Community Health Systems, Inc.

Community Health Systems, Inc. is one of the largest publicly traded hospital companies in the United States and a leading operator of general acute care hospitals in communities across the country. The Company, through its subsidiaries, owns, leases or operates 158 affiliated hospitals in 22 states with an aggregate of nearly 27,000 licensed beds. The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” More information about the Company can be found on its website at www.chs.net.

Forward-Looking Statements

Statements contained in this news release regarding potential transactions, operating results, and other events are forward-looking statements that involve risk and uncertainties. Actual future events or results may differ materially from these statements. Readers are referred to the documents filed by Community Health Systems, Inc. with the Securities and Exchange Commission, including the Company’s annual report on Form 10-K, current reports on Form 8-K and quarterly reports on Form 10-Q. These filings identify important risk factors and other uncertainties that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

EN
18/01/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Community Health Systems Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Magnificent Seven's Turn to Shine We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). We will maintain our bullish intermediate-term outlook as long as market dynamics remain healthy and the S&P 500 (SPX) is above 6200 (up from 6028-6059). Additionally, we discussed since our 10/14/25 Compass how our near-term bullish outlook remains intact as long as the SPX holds above 6550-6569, which coincided with the ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

SPX Testing Resistance as Rate Cut Cycle Begins The S&P 500 (SPX) is back to test YTD highs and important resistance in the 5670-5783 range. This is an important target/resistance area we have discussed for weeks; using the 2007 SPX topping analog which has tracked the current market almost perfectly, it would suggest a 2% or less move above the prior all-time high set in July at 5670 before topping, which is where we get the 5783 number. As long as the SPX does not have a weekly close above 57...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Upgrading Consumer Staples, Real Estate, and Health Care to Overweight; List of Concerns Continues to Grow Our long-term outlook remains neutral on the S&P 500 (SPX) as of our 8/6/24 Compass, after being bullish since early-November 2023. In late-July (7/30/24 Compass) we discussed expectations for a 1- to 4-month pullback/consolidation period on the SPX and Nasdaq 100 (QQQ), and at this point it seems likely to last closer to four months, and potentially 4- to 6-months from our selected 7/17/2...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch